Celeris Therapeutics Company

Harnessing deep learning and lab automation to accelerate drug discovery in targeted protein degradation.

Last Funding Type: Seed
Funding Status: Seed
Headquarters: Menlo Park, California, United States
Founded Date: 2021-01-01
Investor Type: hi@celeristx.com
Last Funding Date: 2022-02-10
Total Funding: 4000000.0
Technology: ['BioTech & HealthTech']
Employee Number: 11-50
Investors Number: 5.0
Industry: Medical BioTech